These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 4999093)

  • 21. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in titer of the naturally occurring human antibody to neuraminidase-treated lymphocytes after influenza.
    Rogentine GN; Doherty CM; Pincus SH
    J Immunol; 1977 Nov; 119(5):1652-4. PubMed ID: 915272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine].
    Dal Fabbro G; Valletta G; Frugoni G; Ricciardi-Tenore N
    Minerva Med; 1972; 63(38):2167-71. PubMed ID: 4664783
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
    Bakke H; Samdal HH; Holst J; Oftung F; Haugen IL; Kristoffersen AC; Haugan A; Janakova L; Korsvold GE; Krogh G; Andersen EA; Djupesland P; Holand T; Rappuoli R; Haneberg B
    Scand J Immunol; 2006 Mar; 63(3):223-31. PubMed ID: 16499576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of immunoglobulins and antibodies to haemaglutinin and neuraminidase of influenza virus in nasal secretions after natural infection.
    Hrusková J; Syrůcek L; Tůmová B; Stumpa A; Brůcková M; Losová M; Berkovicová V
    Acta Virol; 1976 Apr; 20(2):126-34. PubMed ID: 5867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.
    Treanor J; Nolan C; O'Brien D; Burt D; Lowell G; Linden J; Fries L
    Vaccine; 2006 Jan; 24(3):254-62. PubMed ID: 16129526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic variation in influenza viruses, with special reference to Hong Kong influenza.
    Webster RG
    Bull World Health Organ; 1969; 41(3):483-5. PubMed ID: 5309459
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody in nasal secretions after intramuscular injection of influenza virus vaccine in persons with chronic bronchopulmonary disease.
    Alford RH
    J Immunol; 1969 Jul; 103(1):20-4. PubMed ID: 5796857
    [No Abstract]   [Full Text] [Related]  

  • 31. [Field trial with a new type of influenza subunit vaccine (author's transl)].
    Kunz C; Hofmann H
    Wien Klin Wochenschr; 1976 Aug; 88(15):504-8. PubMed ID: 997532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus.
    Alford RH; Rossen RD; Butler WT; Kasel JA
    J Immunol; 1967 Apr; 98(4):724-31. PubMed ID: 4164554
    [No Abstract]   [Full Text] [Related]  

  • 33. Serological diagnosis of human influenza infections by immunoprecipitin techniques.
    Schild GC; Winter WD; Brand CM
    Bull World Health Organ; 1971; 45(4):465-71. PubMed ID: 5004707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody response in respiratory secretions of volunteers given live and dead influenza virus.
    Mann JJ; Waldman RH; Togo Y; Heiner GG; Dawkins AT; Kasel JA
    J Immunol; 1968 Apr; 100(4):726-35. PubMed ID: 5645216
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response in volunteers to intranasal inoculation with freeze-dried influenza Q/Hong Kong/68 vaccine.
    Potter CW; Jennings R; McLaren C; Clarke A
    J Biol Stand; 1975; 3(1):41-50. PubMed ID: 1126961
    [No Abstract]   [Full Text] [Related]  

  • 37. Study of the avidity of anti-influenza antibodies in sera of convalescents or subjects vaccinated with a live influenza virus vaccine.
    Kallas EV; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1969 Nov; 13(6):489-98. PubMed ID: 4391716
    [No Abstract]   [Full Text] [Related]  

  • 38. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology.
    Petrescu A; Mihail A; Samuel I; Teodosiu O; Isaia G; Ganea E; Motaş C
    Virologie; 1979; 30(2):109-15. PubMed ID: 111408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretory immune response after nasal vaccination with live attenuated influenza viruses.
    Crifö S; Vella S; Filiaci F; Resta S; Rocchi G
    Rhinology; 1980 Jun; 18(2):87-92. PubMed ID: 7403787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.